Limited Suppliers and Difficulty Finding Alternatives for Insecticide Active Ingredients
First written in FY2016. 12 of 14 entries say "Restated". Latest entry: FY2023-Q3.
The whole theme swung hardest in 2025: 4 of 16 companies on the "Worse" side.
22 other companies' latest entry also says "Restated".
- FY2023-Q3RestatedAnnual report
「During the cumulative consolidated period of the third quarter, there were no material changes in unusual fluctuations, etc., in financial position, operating results or cash flows, or in the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
殺虫原体の仕入先限定・価格変動リスクについて重要な変更はないと記載している。 - FY2021MitigatedAnnual report
「このようなリスクを認識した上で、当社グループでは処方の変更、複数社購買、グローバル調達などによる継続的なコストダウンに取り組むなど、リスク回避に努めています。」
一部殺虫原体の仕入先限定リスクに対し、処方変更、複数社購買、グローバル調達を対応策として明示した。 - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that management recognizes could materially affect the financial position, operating results and cash flows of the consolidated companies, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
殺虫原体の仕入先限定・価格変動リスクについて重要な変更はないと記載している。 - FY2021-Q1RestatedAnnual report
「During the cumulative consolidated period of the first quarter, there were no material changes in unusual fluctuations, etc., in financial position, operating results or cash flows, or in the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
殺虫原体の仕入先限定・価格変動リスクについて、重要な変更はないと記載している。 - FY2019-Q3RestatedAnnual report
「During the cumulative consolidated period of the third quarter, there were no material changes in unusual fluctuations, etc., in financial position, operating results or cash flows, or in the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
殺虫原体の仕入先限定・価格変動リスクについて重要な変更はないと記載している。 - FY2019-Q2RestatedAnnual report
「During the cumulative consolidated period of the second quarter, there were no material changes in unusual fluctuations, etc., in financial position, operating results or cash flows, or in the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
殺虫原体の仕入先限定・価格変動リスクについて重要な変更はないと記載している。 - FY2019-Q1RestatedAnnual report
「During the cumulative consolidated period of the first quarter, there were no material changes in unusual fluctuations, etc., in financial position, operating results or cash flows, or in the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
殺虫原体の仕入先限定・価格変動リスクについて、重要な変更はないと記載している。 - FY2018-Q3RestatedAnnual report
「During the cumulative consolidated period of the third quarter, there were no material changes in unusual fluctuations, etc., in financial position, operating results or cash flows, or in the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
殺虫原体の仕入先限定・価格変動リスクについて重要な変更はないと記載している。 - FY2018-Q2RestatedAnnual report
「During the cumulative consolidated period of the second quarter, there were no material changes in unusual fluctuations, etc., in financial position, operating results or cash flows, or in the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
殺虫原体の仕入先限定・価格変動リスクについて重要な変更はないと記載している。 - FY2018-Q1RestatedAnnual report
「During the cumulative consolidated period of the first quarter, there were no material changes in unusual fluctuations, etc., in financial position, operating results or cash flows, or in the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
殺虫原体の仕入先限定・価格変動リスクについて、重要な変更はないと記載している。 - FY2017RestatedAnnual report
「一部についてメーカーが限定されており、当該メーカーとの取引が継続困難となった場合や、仕入価格に大きな変動が起こった場合には、業績に影響を及ぼす可能性があります。」
殺虫原体の仕入先限定と取引継続困難・価格変動リスクを引き続き明示している。 - FY2017-Q3RestatedAnnual report
「During the cumulative consolidated period of the third quarter, there were no material changes in unusual fluctuations, etc., in financial position, operating results or cash flows, or in the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
殺虫原体の仕入先限定・代替困難リスクについて重要な変更はないと記載している。 - FY2017-Q2RestatedAnnual report
「During the cumulative consolidated period of the second quarter, there were no material changes in unusual fluctuations, etc., in financial position, operating results or cash flows, or in the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
殺虫原体の仕入先限定・代替困難リスクについて重要な変更はないと記載している。 - FY2016First statedAnnual report
「We purchase most insecticide active ingredients from manufacturers in Japan and overseas, but the number of manufacturers is limited for some ingredients. If it becomes difficult to continue transactions with those manufacturers or procurement prices fluctuate significantly, this could affect our business performance.」
The risk that some insecticide active ingredients have limited suppliers, making continued transactions difficult or exposing the Group to price fluctuations, is disclosed.